TheraCryf announces shareholder meeting notice
- TheraCryf will hold a general meeting in London on Sept. 7, 2026.
- Shareholders will vote on a share subdivision, creating one New Ordinary Share plus four Deferred Shares for each Existing Ordinary Share.
- The meeting will also seek authority to issue 416,388,888 Placing Shares, 166,944,440 Subscription Shares, plus 53,194,443 New Ordinary Shares linked to broker warrants.
- A separate resolution would waive pre-emption rights for those new share issues tied to the capital raising.
- Investors will also vote to adopt amended articles of association aligned with the subdivision.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TheraCryf plc published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Trade now！
You may also like
Crypto prices
More
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now